No, he got suspended because he would not waiver on the matter that all of the ailments that you had described were not viruses. I had done my homework, since everything you posted was well-known even two years ago, in the other thread which ran into 39 pages of debate.
All of Dr. Broxmeyer's papers are peer-reviewed. Especially this one, which was published in the most prestigious medical journal in the world:
Broxmeyer, L., Sosnowska, D., Miltner, E., Chacon, O., Wagner, D., McGarvey, J., Barletta, R.G. and Bermuddez, L.E. (2002) Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J Infect Dis 186,
1155–1160
https://academic.oup.com/jid/article/186/8/1155/2191390The Journal of Infectious Diseases
Oxford Academic
Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.
We are currently exploring the use of other mycobacteriophages and attenuated mycobacterial strains of M. avium and M. tuberculosis, as well as bacille Calmette-Guerin as potential phage delivery systems.
All of his papers which describe zika, ebola, H1N1, as having been caused by mycobacteria are peer-reviewed. That is why he is a very credible source.
What about the credibility of the medical doctors you believe in?
https://www.fda.gov/media/134922/downloadThis test cannot rule out diseases caused by other bacterial or viral pathogens.
Positive results are indicative of active infection with 2019-nCoV but do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
Always, one needs to test for BOTH viruses and mycobacteria. Did your medical doctors perform these tests? All of them have refused to test for mycobacteria.
But not L. Broxmeyer.
https://www.academia.edu/43416919/How_BCG_Vaccination_Trials_Might_Finally_Unlock_the_Many_Mysteries_of_COVID_19_ (pg 9-12)
Can you explain to your readers why Sars-Cov-2 has so many bacterial epitopes?
Out of nine sites, seven sites showed molecular similarity with 54 antigenic determinants found in
twelve pathogenic bacterial species (Mycobacterium tuberculosis, Mycobacterium leprae, Bacillus anthracis, Borrelia burgdorferi, Clostridium perfringens, Clostridium tetani, Helicobacter Pylori, Listeria monocytogenes, Staphylococcus aureus, Streptococcus pyogenes, Vibrio cholera and Yersinia pestis), two malarial parasites (Plasmodium falciparum and Plasmodium knowlesi) and influenza virus A.
Most of the bacterial antigens that displayed molecular similarity with antigenic sites in SARS-CoV-2 RBD (receptor binding domain) were toxins and virulent factors. Antigens from
Mycobacterium that showed similarity were mainly involved in modulating host cell immune response and ensuring persistence and survival of pathogen in host cells.
https://www.sciencedirect.com/science/article/pii/S0171298521000395